UNSPSC 51352204: Diethylstilbestrol

This classification denotes a non-steroidal estrogen with the molecular formula C18H20O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 731DCA35BT, chemically known as phenol, 4,4-(1,2-diethyl-1,2-ethenediyl)bis- but generally known as diethylstilbestrol, which bears US NIH Compound Identifier 3054. European Medicines Agency schedules Diethylstilbestrol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07112MIG. The term DIETHYLSTILBESTROL is an International Non-Proprietary Name.

UNSPSC 51352204 Diethylstilbestrol is a Commodity code that captures pharmaceutical manufacturing and supply agreements for generic multi-source drugs distributed through state and local government health systems and facilities. State and local procurement under this code centers on establishing master supply contracts with pharmaceutical manufacturers that feed inventory through authorized wholesale distributors to public health agencies, correctional facilities, and other government health programs. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, is the primary issuing body visible in recent activity, procuring on behalf of participating state and local members across multiple states including Oregon. These solicitations target manufacturers capable of meeting cGMP and Drug Supply Chain Security Act compliance, maintaining relationships with multiple authorized wholesalers (AmerisourceBergen Drug Corporation/Cencora, Cardinal Health, and Morris & Dickson Co., LLC), and delivering detailed product specifications including National Drug Codes, SKUs, UPCs, strength, dosage form, and packaging configurations.

MMCAP's January 2026 RFP for Generic Multi-Source Pharmaceuticals and OTC Products (S1070000015802, due March 26, 2026) represents the current active opportunity under this code. The contract term runs two years for new vendors with optional extensions; incumbent vendors' amendments extend through June 30, 2028. Evaluation weighs price competitiveness at 75 percent, with the remaining 25 percent distributed across fixed pricing (10 percent), administrative fee compliance (5 percent), EDI capability (5 percent), and format compliance (5 percent). Vendors must accept a 3 percent administrative fee on all purchases, carry $5 million general liability and $2 million network security and privacy liability insurance, and face performance penalties of $200 to $1,500 per violation for late reporting, missed onboarding, or improper class-of-trade denials. Award values are not disclosed in the solicitation; the contract becomes effective July 1, 2026, contingent on all products achieving marketplace availability by May 15, 2026.